Literature DB >> 11805282

Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.

Stijn Heessen1, Ainars Leonchiks, Natalia Issaeva, Anatoly Sharipo, Galina Selivanova, Maria G Masucci, Nico P Dantuma.   

Abstract

Functional inactivation of the tumor suppressor protein p53 by accelerated ubiquitin/proteasome-dependent proteolysis is a common event in tumor progression. Proteasomal degradation is inhibited by the Gly-Ala repeat (GAr) of the Epstein-Barr virus nuclear antigen-1, which acts as a transferable element on a variety of proteasomal substrates. We demonstrate that p53 chimeras containing GAr domains of different lengths and positions within the protein are protected from proteolysis induced by the ubiquitin ligases murine double minute 2 and E6-associated protein but are still ubiquitinated and retain the capacity to interact with the S5a ubiquitin-binding subunit of the proteasome. The GAr chimeras transactivate p53 target genes, induce cell cycle arrest and apoptosis, and exhibit improved growth inhibitory activity in tumor cells with impaired endogenous p53 activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805282      PMCID: PMC122225          DOI: 10.1073/pnas.022306499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  p53: death star.

Authors:  K H Vousden
Journal:  Cell       Date:  2000-11-22       Impact factor: 41.582

2.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

3.  An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.

Authors:  S D Boyd; K Y Tsai; T Jacks
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

4.  Mdm2 inhibits the apoptotic function of p53 mainly by targeting it for degradation.

Authors:  D B Yap; J K Hsieh; X Lu
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

5.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.

Authors:  M Scheffner; K Münger; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

7.  Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

Authors:  S Ries; C Biederer; D Woods; O Shifman; S Shirasawa; T Sasazuki; M McMahon; M Oren; F McCormick
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

8.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

9.  A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.

Authors:  L Li; J Liao; J Ruland; T W Mak; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

10.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

View more
  10 in total

1.  Topographically induced self-deformation of the nuclei of cells: dependence on cell type and proposed mechanisms.

Authors:  Patricia M Davidson; Olivia Fromigué; Pierre J Marie; Vasif Hasirci; Günter Reiter; Karine Anselme
Journal:  J Mater Sci Mater Med       Date:  2009-12-10       Impact factor: 3.896

2.  Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processing.

Authors:  Chrysoula Daskalogianni; Sébastien Apcher; Marco M Candeias; Nadia Naski; Fabien Calvo; Robin Fåhraeus
Journal:  J Biol Chem       Date:  2008-08-29       Impact factor: 5.157

3.  High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.

Authors:  Giuseppe Coppotelli; Nouman Mughal; Diego Marescotti; Maria G Masucci
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

4.  Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion.

Authors:  Elisabeth L Pagé; Denise A Chan; Amato J Giaccia; Mark Levine; Darren E Richard
Journal:  Mol Biol Cell       Date:  2007-10-17       Impact factor: 4.138

5.  The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system.

Authors:  Ronen Sadeh; Kristin Breitschopf; Beatrice Bercovich; Muhammad Zoabi; Yelena Kravtsova-Ivantsiv; Daniel Kornitzer; Alan Schwartz; Aaron Ciechanover
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

6.  Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.

Authors:  Kristina Lindsten; Femke M S de Vrij; Lisette G G C Verhoef; David F Fischer; Fred W van Leeuwen; Elly M Hol; Maria G Masucci; Nico P Dantuma
Journal:  J Cell Biol       Date:  2002-04-29       Impact factor: 10.539

7.  The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.

Authors:  Beatrice Ondondo; Lee Faulkner; Neil A Williams; Andrew J Morgan; David J Morgan
Journal:  Cancer Med       Date:  2015-02-02       Impact factor: 4.452

8.  CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.

Authors:  Steven P Lee; Jill M Brooks; Hatim Al-Jarrah; Wendy A Thomas; Tracey A Haigh; Graham S Taylor; Sibille Humme; Aloys Schepers; Wolfgang Hammerschmidt; John L Yates; Alan B Rickinson; Neil W Blake
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

Review 9.  The Epstein-Barr Virus EBNA1 Protein.

Authors:  Lori Frappier
Journal:  Scientifica (Cairo)       Date:  2012-12-19

Review 10.  The Critical Role of Genome Maintenance Proteins in Immune Evasion During Gammaherpesvirus Latency.

Authors:  Océane Sorel; Benjamin G Dewals
Journal:  Front Microbiol       Date:  2019-01-09       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.